SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-010065
Filing Date
2017-05-10
Accepted
2017-05-10 08:01:18
Documents
59
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q dmtx-10q_20170331.htm 10-Q 1823819
2 EX-10.1 dmtx-ex101_6.htm EX-10.1 72046
3 EX-31.1 dmtx-ex311_8.htm EX-31.1 13345
4 EX-31.2 dmtx-ex312_7.htm EX-31.2 13340
5 EX-32.1 dmtx-ex321_9.htm EX-32.1 15399
6 GRAPHIC g20170509175644372140.jpg GRAPHIC 23867
  Complete submission text file 0001564590-17-010065.txt   5977613

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT dmtx-20170331.xml EX-101.INS 1283927
8 XBRL TAXONOMY EXTENSION SCHEMA dmtx-20170331.xsd EX-101.SCH 39550
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE dmtx-20170331_cal.xml EX-101.CAL 44835
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dmtx-20170331_def.xml EX-101.DEF 107633
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE dmtx-20170331_lab.xml EX-101.LAB 302585
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dmtx-20170331_pre.xml EX-101.PRE 232871
Mailing Address 840 MEMORIAL DRIVE 4TH FLOOR CAMBRIDGE MA 02139
Business Address 840 MEMORIAL DRIVE 4TH FLOOR CAMBRIDGE MA 02139 617-401-0011
Dimension Therapeutics, Inc. (Filer) CIK: 0001592288 (see all company filings)

IRS No.: 463942159 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37601 | Film No.: 17828527
SIC: 2836 Biological Products, (No Diagnostic Substances)